Associate Director, Patient Services Operations at Acadia Pharmaceuticals

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiopharmaceuticalsIndustries

Requirements

The Associate Director, Patient Services Operations should have experience managing day-to-day hub operations for a patient services program, including overseeing KPIs, resolving operational challenges, and ensuring accurate reporting. Experience in monitoring program budgets and ensuring compliance with legal, regulatory, and pharmacovigilance requirements is necessary. The role requires interaction with brand teams and internal functions such as finance, legal, safety, and quality. Experience in team leadership, vendor management, and co-pay program oversight is also required.

Responsibilities

The Associate Director, Patient Services Operations will lead a team responsible for specialty pharmacy access, reimbursement, and affordability. Responsibilities include ensuring program operations run smoothly, managing vendor relationships, overseeing the co-pay program, and collaborating with internal teams for reporting and data analysis. This role also involves ensuring timely reporting of adverse events and product complaints, supporting budget development and forecasting, and maintaining communication between patient access support teams and the MAP team.

Skills

team leadership

specialty pharmacy operations

reimbursement

affordability programs

program operations

KPI management

budgeting

regulatory compliance

pharmacovigilance

cross-functional collaboration

data reporting

risk and issue resolution

training and development

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free